When Teen Girls Have Irregular Periods and No Doctor Investigates, Here Is What They Lose

Aishwarya Kapoor | Times Life Bureau | Jul 29, 2026, 07:02 IST
Share
When Teen Girls Have Irregular Periods and No Doctor Investigates, Here Is What They Lose
When Teen Girls Have Irregular Periods and No Doctor Investigates, Here Is What They Lose
Image credit : Times Life Bureau

Irregular periods in adolescent girls are routinely dismissed as normal variation. They are not always. Behind an uninvestigated irregular cycle can be PCOS, thyroid dysfunction, or early hormonal disruption that shapes fertility, bone density, and metabolic health for decades. What gets lost is a diagnostic window that closes quietly, and rarely reopens on the same terms.

What "Normal Variation" Is Actually Covering Up

A girl's first few menstrual cycles are expected to be irregular. Textbook guidance allows up to two years of cycle variation after menarche before flagging concern. That window is clinically reasonable. The problem is that the window gets extended indefinitely, by busy paediatricians, by mothers who remember their own chaotic early cycles, by a cultural tendency to treat menstruation as something a girl manages privately rather than something a doctor tracks.
A 2020 study published in the Journal of Pediatric and Adolescent Gynecology found that among adolescent girls presenting with menstrual irregularity, fewer than 40% received any hormonal evaluation within the first year of reporting symptoms. The rest were told to wait and see. In many cases, waiting and seeing is exactly what erases the early signal.
Irregular cycles are not a diagnosis. They are a symptom. The distinction matters enormously at this age, because the conditions they point toward are far easier to manage when caught before they have had years to calcify into chronic dysfunction.

The Conditions Hiding Behind an Uninvestigated Cycle

Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, affecting an estimated 1 in 5 Indian women according to a 2022 review in the Indian Journal of Endocrinology and Metabolism. PCOS frequently announces itself in adolescence through irregular or absent periods, acne, and weight changes, all of which are individually easy to dismiss as puberty. Together, they are a pattern worth investigating. A simple ultrasound and a testosterone and LH/FSH panel can flag it. Most teen girls in India never get either.
Thyroid dysfunction is the second condition that commonly surfaces this way. Hypothyroidism slows the hormonal cascade that triggers ovulation, producing long, unpredictable, or skipped cycles. A TSH test costs under two hundred rupees at most diagnostic chains. It is not routinely ordered.

Hyperprolactinemia, premature ovarian insufficiency, and functional hypothalamic amenorrhea round out the differential. Each has a different cause, a different treatment path, and a different long-term risk profile. None can be distinguished from the others without bloodwork. Telling a girl her cycle will regulate itself is not reassurance. It is a decision not to look.

The Cost of Not Looking

Bone density peaks between ages 16 and 25. Oestrogen is the primary driver of that accumulation. A girl with chronically low oestrogen output, from PCOS, from hypothalamic suppression, from thyroid disruption, is not building the bone mass her skeleton needs for the next six decades. She will not feel this. There is no pain, no visible sign. The deficit shows up in a DEXA scan at 45 and looks like early osteoporosis with no obvious cause.
The fertility cost is better understood but still underestimated. Ovulation is not guaranteed simply because menstruation occurs. Anovulatory cycles, in which a period happens but no egg is released, are common in unmanaged PCOS and thyroid disorders. A girl who bleeds irregularly through her teens and twenties may discover in her early thirties that she has been anovulatory for years. The treatment options at that point are more invasive, more expensive, and less reliable than the metformin or levothyroxine that would have been prescribed at sixteen.

The metabolic picture is equally serious. Insulin resistance, which underlies most PCOS cases, compounds over time. Left unaddressed through adolescence, it increases the long-term risk of type 2 diabetes and cardiovascular disease. A 2019 paper in Fertility and Sterility estimated that women with PCOS have a 2.5-fold higher lifetime risk of developing type 2 diabetes compared to women without the condition.

Why Indian Adolescent Girls Are Particularly Under-Investigated

The barriers are specific and worth naming. Menstruation is still discussed in lowered voices in most Indian households. A girl whose cycle is irregular is far more likely to hear that this is normal, that it will settle after marriage, or that stress from board exams is the cause, than she is to be taken to a gynaecologist. The marriage explanation is particularly damaging: it defers investigation by a decade and reframes a medical question as a domestic one.
The healthcare routing adds another layer. Paediatricians in India typically see patients through age 12 or 13, then discharge them. Gynaecologists are culturally coded as doctors for married women or pregnant women. The adolescent girl falls into a gap between the two, seen by neither specialist with any regularity. Her annual check-up, if she has one, is with a general physician who is unlikely to probe menstrual history in detail.

Awareness among parents is also genuinely low. Research from the National Family Health Survey data has consistently shown that menstrual health knowledge among Indian mothers, particularly in semi-urban and rural settings, does not extend much beyond hygiene. The idea that an irregular period in a 15-year-old might warrant a blood test is simply not on the radar.

What a Proper Workup Actually Involves

It is not complicated. For an adolescent presenting with cycles that are consistently shorter than 21 days, longer than 45 days, or absent for more than 90 days after two years post-menarche, the standard evaluation includes: a TSH test, an LH/FSH ratio, a prolactin level, a testosterone measurement, and a pelvic ultrasound. In girls with significant weight change or acne, a fasting insulin and glucose are added. This panel, at a mid-range diagnostic lab in any Indian city, costs between 1,500 and 3,000 rupees.
The results either rule out a condition or point toward one. If they point toward one, treatment at this stage is usually straightforward: lifestyle modification and metformin for insulin-resistant PCOS, levothyroxine for hypothyroidism, a careful assessment of energy intake for hypothalamic amenorrhea. None of these are aggressive interventions. They are the kind of thing that is easy to do at 15 and considerably harder to undo the consequences of at 35.
The gap between what is possible and what actually happens for most adolescent girls in India is not a gap in medical knowledge. The protocols exist. The tests are affordable. What is missing is the expectation that a teenage girl's menstrual cycle deserves the same investigative attention as any other symptom that shows up and does not resolve.
An irregular period in a teen is not a footnote to puberty. It is a signal from a hormonal system that is either calibrating correctly or not, and the only way to know which is to check. The window for catching it early, for preserving bone, for protecting ovulation, for reducing metabolic risk, does not stay open indefinitely. It closes on a schedule the girl cannot feel and most of the adults around her are not watching.